- a crystalline, slightly water-soluble solid, C13H10N2O4, formerly used as a sedative: if taken during pregnancy, it may cause severe abnormalities in the limbs of the fetus.
Origin of thalidomide
- a synthetic drug formerly used as a sedative and hypnotic but withdrawn from the market when found to cause abnormalities in developing fetuses. Formula: C 13 H 10 N 2 O 4
- (as modifier)a thalidomide baby
Word Origin for thalidomide
1958, from "phthalimidoglutarimide," based on abbreviated form of naphthalene; a morning-sickness drug responsible for severe birth defects in Europe from 1956 to 1961, when it was withdrawn. It never was approved for use in America thanks to the efforts of Dr. Helen Brooke Taussig (1898-1986). Thalidomide baby is attested from 1962.
- A sedative and hypnotic drug that was withdrawn from sale after it was found to cause severe birth defects when taken during pregnancy.
- A drug used to treat leprosy. It was previously prescribed to treat nausea during early pregnancy, but was found to cause severe birth defects, including stunting or absence of the limbs. Chemical formula: C13H10N2O4.
A sedative drug that was developed and used in Europe in the 1960s. Thalidomide was taken off the market when it became evident that it caused severe birth defects in babies born to women who had used the drug during pregnancy.